Mortality in Paediatric PH

Presented at PVRI 2026 Congress by Humberto Garcia Aguilar, Centro Medico Nacional 20 de Noviembre

Summary
PAH in children presents unique challenges and treatment options. Early intervention is crucial, and recent studies show significant improvements in management with macitentan. Key mortality factors include functional class and genetic traits. The need for better access to medications and specialised training in expert centres is emphasised to enhance patient outcomes.
 

Generated by AI, edited by PVRI